ACM
AlphaCrest Capital Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,823
| Closed | -$287K | – | 404 |
|
|
2022
Q3 | $287K | Buy |
+12,823
| New | +$287K | 0.02% | 1152 |
|
|
2021
Q4 | – | Sell |
-7,147
| Closed | -$424K | – | 1386 |
|
|
2021
Q3 | $424K | Sell |
7,147
-8,746
| -55% | -$519K | 0.02% | 979 |
|
|
2021
Q2 | $1.38M | Buy |
15,893
+12,866
| +425% | +$1.12M | 0.06% | 509 |
|
|
2021
Q1 | $250K | Buy |
+3,027
| New | +$250K | 0.01% | 1077 |
|
|
2020
Q4 | – | Sell |
-10,500
| Closed | -$420K | – | 1163 |
|
|
2020
Q3 | $420K | Buy |
+10,500
| New | +$420K | 0.05% | 691 |
|
|
2020
Q2 | – | Sell |
-9,460
| Closed | -$210K | – | 969 |
|
|
2020
Q1 | $210K | Buy |
+9,460
| New | +$210K | 0.03% | 922 |
|